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Objectives. This study sought to determine whether chronic
atrial fibrillation (AF) and atrial flutter in patients lead to
electrical remodeling of the human atrial myocardium, mani-
fested by an abnormal relation between atrial cycle length and
action potential duration (APD).
Background. Experimental studies in goats and isolated human
atrial tissue have shown that prolonged AF leads to persistent
shortening of atrial refractoriness, a phenomenon referred to as
electrical remodeling and which helps to explain why AF begets
AF. Direct data on human in situ myocardium are still lacking.
Methods. Using monophasic action potential recordings at two
right atrial sites simultaneously, we determined in 7 patients with
chronic AF and 13 with chronic atrial flutter (3 weeks to 3 years
in duration) the relation between paced cycle length and APD at
90% repolarization (APD90) 15 to 30 min after conversion to sinus
rhythm. APD90 was measured during regularly paced cycle
lengths (250 to 800 ms) to determine the steady state cycle length
relation and during extrastimulus intervals (from 800 ms to
refractoriness) at a basic cycle length of 600 ms to determine
electrical restitution curves. The same pacing protocols and
measurements were performed in nine control patients with sinus
rhythm and no overt atrial disease.
Results. In control patients, steady state APD90 increased
steadily with increases in cycle length from 250 to 800 ms,
reaching a maximal value of 325 6 41 ms (mean 6 SD) at a cycle
length of 800 ms. In patients with cardioversion from atrial flutter
or AF, the steady state cycle length–APD90 relation was shifted
downward and flattened at cycle lengths >400 ms, reaching only
219 6 44 and 245 6 39 ms, respectively, at the 800-ms cycle length
(p < 0.005 vs. control). The early time course of electrical
restitution (200- to 300-ms extrastimulus intervals) was similar
between all three groups, but at extrastimulus intervals >350 ms,
APD90 was shorter in both the AF and atrial flutter groups than
in the control group (p < 0.05). There were no significant
differences between patients with cardioversion from atrial flutter
and those with cardioversion from AF. APD90 at a steady state
cycle length of 600 ms showed no significant correlation with the
duration of previous AF or atrial flutter.
Conclusions. AF and atrial flutter lead to marked, quantita-
tively similar decreases in the right atrial APD during steady state
pacing and extrastimulation a considerable time after cardiover-
sion. These data confirm that both AF and atrial flutter lead to
electrical remodeling in the human atrium, with a preponderance
at longer cycle lengths. It may be prudent to abort both types of
arrhythmias early to prevent electrical remodeling.
(J Am Coll Cardiol 1997;30:1785–92)
©1997 by the American College of Cardiology
Clinical experience suggests that atrial fibrillation is a self-
promoting electrical disease. Paroxysmal atrial fibrillation
(AF) frequently progresses to chronic AF (1,2), and sinus
rhythm becomes less sustainable after electrical or pharmaco-
logic conversion of AF the longer AF lasts (3–5). Although
underlying anatomic or pathophysiologic factors (2,6–10) may
fuel the progression from paroxysmal to chronic AF, recent
data suggest that AF itself may lead to its own progression and,
eventually, chronic manifestation. Wijffels et al. (11) showed in
conscious goats that the more frequently AF is induced or the
longer AF is maintained, the more easily inducible and the
more sustained AF becomes. This finding led Wijffels et al. to
coin the term “electrical remodeling.” Their study (11) further
demonstrated that the increased propensity for AF, condi-
tioned by AF, was associated with an abnormal rate adaptation
of the atrial effective refractory period compared with its
pre-AF baseline state, thus providing a possible explanation
for why “AF begets AF”. Recently, Daoud et al. (12) showed
in humans that just several minutes of electrically induced AF
shortens the atrial effective refractory period for up to 8 min
and that this shortening correlates with an increased propen-
sity for the induction of secondary AF.
There has not yet been a systematic investigation of how
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chronic clinical AF may alter the normal relation between
cycle length and action potential duration (APD) in the human
atrium. The same information is lacking for chronic atrial
flutter. Clinical data (1) suggest that atrial flutter if untreated
may eventually lead to AF. It is plausible to assume that atrial
flutter also leads to electrical remodeling and by doing so may
facilitate degeneration into AF (13). Therefore, the present
study sought to determine whether and to what extent atrial
electrical remodeling develops in patients with either chronic
AF or atrial flutter. To this end, we determined the relation
between paced cycle length and right atrial monophasic APDs
15 to 30 min after cardioversion from either chronic AF or
atrial flutter. These data were obtained over the entire range of
regularly pacable cycle lengths as well as during extrastimula-
tion to define both the steady state rate adaptation and
electrical restitution curves. A control group with sinus rhythm
and no overt atrial disease was studied for comparison.
Methods
Patients. The study was performed at the Veteran Affairs
Medical Center, Washington, D.C. and included 29 consecu-
tively enrolled male patients. The pertinent clinical and elec-
trophysiologic features are presented in Table 1. All patients
underwent electrophysiologic study after signing an informed
consent form that was approved by our institution’s committee
on human investigation. No patient received antiarrhythmic
drugs 5 half-times before the study. Nine patients were in sinus
rhythm, had no known atrial or valvular disease and had
structurally normal atria. These patients were evaluated for
paroxysmal atrioventricular (AV) node reentrant tachycardias
or ventricular tachycardia and constituted the control group.
Seven patients had chronic AF known to have lasted from 3
weeks to 3 years, and 13 patients had atrial flutter 0.8 to 32
months in duration. These patients underwent electrical car-
dioversion in the electrophysiology laboratory, either by over-
drive pacing or transthoracic shock. Preexisting anticoagula-
tion therapy with Coumadin was replaced by heparin 1 to 3
days before the study. Data on left atrial diameter and left
ventricular ejection fraction were obtained by echocardiogra-
phy or angiography, respectively, 1 to 5 days before the
electrophysiologic study.
All patients underwent instrumentation with two monopha-
sic action potential (MAP) pacing catheters (EP Technologies,
Inc.) (14), one placed at the high right atrium and the other at
the low right atrium. In all patients, MAPs were recorded
during sinus rhythm (control patients) or during AF or atrial
flutter before cardioversion to assess the average cycle length
and APD for each group.
Cardioversion. In all patients with atrial fibrillation, car-
dioversion was performed with a transthoracic electrical shock
of 200 to 360 J. In 3 of the 13 patients with atrial flutter,
cardioversion was performed by rapid overdrive pacing that
resulted in cardioversion within 1 to 2 min. In seven patients in
whom overdrive pacing was unsuccessful despite attempts for
5 min (AF occurred in three of them), cardioversion was
achieved by transthoracic shock. In the remaining three pa-
tients, atrial flutter was terminated by radiofrequency catheter
ablation that targeted the isthmus between the inferior vena
cava and the tricuspid valve ring.
Pacing protocols. After restoration of sinus rhythm, a
15-min waiting period was observed to allow short-term rate-
dependent changes in APD to dissipate (15). Pacing with twice
diastolic threshold stimuli was then begun from the MAP
pacing catheter positioned in the high right atrium. Two pacing
protocols were applied in the following sequence.
Steady state pacing. Pacing was begun at the longest cycle
length that was not interrupted by escape beats. After 1 min of
regular pacing, the cycle length was decremented by 100 ms
without intermittent pause, and this sequence was repeated
until a cycle length of 300 ms was reached. The last decrement
was 50 ms, resulting in a minimal steady state cycle length of
250 ms.
Extrastimulation. The purpose of this protocol was to de-
fine the electrical restitution curve, which is known to charac-
terize the short-term recovery of the APD from 1 beat to the
next (15–17). The atrium was paced at a basic cycle length of
600 ms, and an extrastimulus was applied at varying coupling
intervals to the last regular beat, starting with the longest
S1–S2 interval possible without escape beats. The S1–S2
intervals were decremented in 50-ms steps until an S1–S2
interval of 400 ms. A subsequent decrement of 20 ms was used
until an S1–S2 interval of 250 ms and a decrement of 10 to 5 ms
until atrial refractoriness occurred. Each S1–S2 interval fol-
lowed 12 regular stimuli at the basic cycle length of 600 ms with
a subsequent 1-s pause and was repeated once to ensure data
reproducibility. Both protocols were completed within 15 min
without needing to change the catheter positions.
Measurements and data analysis. MAP recordings and a
simultaneous 12-lead electrocardiogram were acquired contin-
uously in digital format on a magneto-optical disk using a
BARD electrophysiology system (USCI). An example of two
simultaneous MAP recordings during pacing at three different
steady state cycle lengths is shown in Figure 1. After the study,
data were downloaded onto a Macintosh computer hard disk
and converted into Macintosh binary format for off-line signal
processing and data analysis. Signals during steady state and
extrastimulus pacing were analyzed for cycle length and
monophasic APD at 90% repolarization (APD90) with a
custom-developed software algorithm written in LabVIEW
language (National Instruments). This automated algorithm
Abbreviations and Acronyms
AF 5 atrial fibrillation
APD 5 action potential duration
APD90 5 action potential duration at 90% repolarization
AV 5 atrioventricular
MAP 5 monophasic action potential
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has been validated previously by two independent manual
observers and shown to be accurate and reliable (18).
Effect on APD90 of duration of AF and atrial flutter before
cardioversion. To examine the influence of the time during
which patients had been in either AF or atrial flutter before
cardioversion, the steady state APD90 at a paced cycle length
of 600 ms (taken from the dataset of the first protocol) was
plotted against the duration of the preexisting arrhythmia.
Statistical methods. Graphical representations of APD90
values are presented as mean value 6 SD. Both the steady
state and S1–S2 APD90 values are presented for the three
groups for cycle lengths up to 800 ms because at longer cycle
lengths, missing values due to escape beats prevented statisti-
cal comparison. To examine differences between patients with
atrial flutter or AF and control subjects, repeated measures
analysis of variance was performed with the diagnostic category
as a three-level between-subjects factor and the pacing cycle
length as a seven-level within-subjects factor (250, 300, 400, 500,
600, 700, 800 ms). Significant main and interaction effects were
further examined with post hoc analyses of variance at each
separate cycle length. A p value ,0.05 was considered statistically
significant. The effect of the duration of AF and atrial flutter on
















73 VT 40 25 910
67 VT 37 60 830
66 VF 34 35 850
81 VT 35 22 672
70 Syncope 40 65 712
61 AV block 32 20 752
73 NSVT 38 45 614
49 AVNRT 42 55 680
Mean 66.67 37.3 40.9 802.7
SD 9.26 3.4 17.9 178.2
Patients With Atrial Flutter
65 Typical 44 56 N/A DCshock 680
63 Typical 32 55 4 DC shock 600
62 Atypical 40 55 12 DC shock 888
63 Typical 40 45 8 Ablation 645
48 Typical 50 25 24 Ablation 790
82 Typical 31 45 4 DC shock 1,152
62 Typical 51 38 1 Pace out 1,200
65 Typical 39 50 9 Pace out 974
82 Typical 37 45 32 DC shock 790
66 Atypical 42 60 0.8 DC shock 640
69 Typical 34 55 1 Ablation 740
57 Typical 38 21 2 Pace out 670
72 Atypical 37 50 4 DC shock 797
Mean 65.8 39.6 46.2 8.5 812.8
SD 11.0 6.8 13.1 11.4 202.0
Patients With Atrial Fibrillation
64 45 20 18 DC shock 830
70 37 40 1 DC shock 600
72 50 40 0.75 DC shock 615
79 40 20 36 DC shock 804
54 46 29 9 DC shock 1,030
64 42 15 1 DC shock 800
63 35 60 3 DC shock 655
Mean 66.6 42.1 32.0 9.8 762.0
SD 8.0 5.3 15.8 13.1 152.2
*Mean age, left atrial (LA) size and postcardioversion sinus cycle length (CL) were not significantly different between
the three groups. AF 5 atrial fibrillation; Aflut 5 atrial flutter; Conv 5 conversion; DC 5 direct current; Dx 5 diagnosis;
LVEF 5 left ventricular ejection fraction; N/A 5 not applicable; Pace out 5 termination of atrial flutter by overdrive pacing.
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the extent of APD90 at a selected cycle length of 600 ms was
evaluated by simple linear regression analysis.
Results
Clinical data. There were no significant differences in left
ventricular ejection fraction and left atrial size between the
three groups. Patients with previous AF had a nonsignificant
trend toward a lower left ventricular ejection fraction than
patients with previous atrial flutter and control patients.
Spontaneous cycle length and APD90 after cardioversion.
All control patients had regular sinus rhythm with cycle lengths
at the time of study, ranging from 672 to 1,204 ms. Spontane-
ous sinus cycle lengths in patients with conversion from AF or
atrial flutter before the start of the steady state and extrastimu-
lus pacing protocols were not significantly different from those
in the control group (Table 1).
Steady state relation between cycle length and APD90.
After each 100-ms decrement in cycle length, APD90 achieved
a new steady state within ;30 to 40 s. The last 5 beats at each
cycle length before switching to the next shorter cycle length at
60 s were analyzed to obtain a representative steady state for
each cycle length. This analysis was done for both right atrial
recordings, and the values for both atrial sites were averaged to
produce steady state plots of APD90 versus cycle length (Fig.
2). In control patients, APD90 increased steadily with in-
creases in the paced cycle length, reaching values of 325 6
41 ms at a paced steady state cycle length of 800 ms. In
contrast, in patients with cardioversion from AF or atrial
flutter, the curve describing the relation between APD90 and
cycle length was shifted downward and flattened, exhibiting a
markedly shorter APD90 at cycle lengths between 400 and
800 ms. Statistically significant shortening of APD90 started to
occur at cycle lengths of 400 ms (p 5 0.015) and was
substantially greater at longer cycle lengths (p , 0.005). At the
longest cycle length of 800 ms, APD90 was approximately 130
to 150 ms shorter in the AF and atrial flutter groups than in the
control group. There were no significant differences in APD90
between patients with cardioversion from atrial flutter and
those with cardioversion from AF at any of the paced cycle
lengths.
Electrical restitution curves. APD90 in response to vari-
able extrastimulus intervals during the 600-ms basic cycle
length pacing was plotted as a function of the respective S1–S2
interval. The longest S1–S2 coupling interval without escape
beats ranged from 750 to 1,200 ms, and the shortest S1–S2
interval (effective refractory period) ranged from 185 to
210 ms. Each extrastimulus interval was repeated, and the
respective responses of both right atrial sites were averaged to
construct electrical restitution curves (Fig. 3). The early time
courses of the electrical restitution curves were nearly identical
for the three groups. However, significant separation occurred
at S1–S2 intervals .350 ms, at which APD90 was shorter in
patients with previous atrial flutter or AF than in control
subjects.
Effect of duration of AF or atrial flutter on postcardiover-
sion steady state APD90. To examine whether the length of
time during which patients had been in either atrial flutter or
AF before cardioversion had an impact on the extent of
electrical remodeling, APD90 at a paced steady state cycle
Figure 1. Example of original electrocar-
diographic (leads II and V1) and MAP
recordings obtained simultaneously at the
high (HRA) and low (LRA) right atrium
during steady state pacing at three different
cycle lengths (CL).
Figure 2. Average APD90 6 SD plotted as a function of steady state
cycle length. Asterisks denote significant differences in average APD90
of patients with AF (AFib) and atrial flutter (AFlut) versus control
patients. There were no significant differences between the AF and
atrial flutter groups.
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length of 600 ms was plotted against the duration of the
preexisting atrial tachyarrhythmia (Fig. 4). There was no
significant influence of the duration of either atrial flutter or
AF on APD90.
Discussion
The present study produced the following main findings: 1)
Sustained AF and atrial flutter both resulted in pronounced
changes of the human in situ atrial APD measured during
steady state pacing 15 to 30 min after cardioversion to sinus
rhythm. Patients with conversion from AF or atrial flutter had
markedly depressed and flattened atrial APD–cycle length
relations, which contrasted significantly with the APD–cycle
length relation measured in the control patients (sinus rhythm)
in whom the APD showed a continuous prolongation with each
increase in cycle length. 2) Despite the slower rate of atrial
flutter than AF, alterations in APD were similar in both the AF
and atrial flutter groups. 3) The duration of previous AF or
atrial flutter (range 3 weeks to 36 months) was found to have
no significant impact on the extent of APD shortening after
cardioversion.
Steady state adaptation of APD. It is well known that the
APD and the associated refractory period bear a close relation
to the cardiac cycle length. In most species, including humans,
the APD increases linearly with cycle length, to reach a plateau
at cycle length $800 ms (15,19). An abrupt decrease in cycle
length leads to a rapid shortening of the APD and the
associated refractory period, which reaches a new steady state
within ,3 min. However, this short-term effect of cardiac rate
memory dissipates equally rapidly on a return to the baseline
cycle length (15,20,21). In contrast, in the study by Wijffels et
al. (11) the refractory period shortening and flattening of the
refractory period–cycle length relation curve caused by AF was
still prevalent hours after conversion to sinus or regularly
paced rhythm. This refractory period shortening was observed
over the entire range of paced cycle lengths, resulting in a flat
or even inverted curve of the refractory period–cycle length
relation.
In the present study in patients, the normal rate adaptation
curve of atrial action potentials (control patients) was very
similar to that previously reported for ventricular action po-
tentials in humans, which also showed a gradual and nearly
linear increase in APD90 with increasing steady state cycle
length (15). In contrast, patients with cardioversion from either
AF or atrial flutter had nearly flat rate adaptation curves. The
most marked lack of rate adaptation was observed during
steady state pacing at long cycle lengths.
These human data correspond well with those reported by
Wijffels et al. (11), who found that in conscious goats that had
no previous atrial disease and were submitted to electrically
induced AF, the atrial refractory period shortened, and the
entire rate adaptation curve flattened or even inverted. Al-
though we did not see inversion of the APD90–cycle length
relation in human atria, the inversion of the refractory period–
cycle length curves shown in several goats in the study by
Wijffels et al. (11) may be explained by the fact that those
individual animals had a less steep increase in the refractory
period toward long cycle lengths compared with other animals
or our control patients. Wijffels et al. (11) also showed that
there was a fairly good correlation between the development of
maladaptation of the atrial refractory period and the probabil-
ity that a premature stimulus would provoke sustained AF. In
an earlier clinical study Attuel et al. (22) found that patients in
whom sustained atrial tachyarrhythmias could be induced by
one to three extrastimuli had a poor or missing rate adaptation
of the atrial refractory period as determined by pacing at three
Figure 3. Average APD90 plotted as a function of S1–S2 intervals at
a basic cycle length of 600 ms (electrical restitution curves). Standard
deviation bars are omitted for clarity. Asterisks denote significant
differences in average APD90 of patients with AF (AFib) and atrial
flutter (AFlut) versus control patients. There were no significant
differences between the AF and atrial flutter groups.
Figure 4. Steady state APD90 at a cycle length of 600 ms plotted as a
function of the duration of the preexisting AF (AFib) or atrial flutter
(AFlut) (lines represent simple regression lines). For the study range
of 3 weeks to 3 years, there was no significant influence of the duration
of the preexisting atrial tachyarrhythmia on the extent of electrical
remodeling.
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or more different basic cycle lengths. Boutjdir et al. (23)
measured the adaptation of the APD to changes in cycle length
in isolated strips of human atrial myocardium and also found
maladaptation in the myocardium of patients prone to AF.
Clinical and experimental studies (23,24) have demonstrated
that patients with recurrent AF have shorter atrial refractory
periods than control patients and patients without recurrence
of AF. These combined findings suggest that the shortening of
the refractory period or APD and the loss of physiologic rate
adaptation may be both the result and a mitigating factor of
AF.
That the duration of either AF or atrial flutter was of no
significance with regard to electrical remodeling may be ex-
plained by the fact that all patients in this study had had one of
these atrial tachyarrhythmias continuously for at least 3 weeks.
This duration may be sufficient or even exceed the time
required to manifest the electrophysiologic changes by a
sustained dramatic increase in atrial activation frequency.
Goette et al. (25) showed that in conscious dogs submitted to
rapid pacing, significant electrical remodeling occurs within
12 h.
Electrical restitution curves. It is well established that the
electrical restitution curve (16) extracts information about
short-term recovery processes of myocardial ion channels as
opposed to long-term or steady-state changes (17,21,26). The
early phase of electrical restitution (at S1–S2 intervals ,180 to
300 ms) was not significantly different between patients with
either previous AF, atrial flutter or sinus rhythm. This finding
suggests that the processes that govern the short-term recovery
of the APD at very short cycle lengths are unchanged by a
history of either sustained atrial flutter or AF and that perhaps
APD shortening at such short intervals has “bottomed out.”
However, at extrastimulus intervals .350 ms, electrical resti-
tution curves in both AF and atrial flutter groups fell well
below that of the control group (Fig. 4). Thus, electrical
remodeling by either AF or atrial flutter is most notable at long
cycle lengths.
Mechanisms underlying electrical remodeling. Adaptation
of the APD or refractory period to increases in rate is
physiologic and follows a rapid and fully reversible time course
(15,19). In contrast, AF and atrial flutter lead to excessive
shortening and delayed recovery. During rapid rates of depo-
larization, the proportion of depolarized state versus repolar-
ized state shifts in favor of the depolarized state. This shift may
cause a net increase in inward calcium current and subsequent
intracellular calcium ion load, which in turn can accelerate
repolarization by inhibiting the L-type calcium inward current
(27) and enhancing the delayed rectifier current (IK) (28).
Chronic AF and atrial flutter and other forms of rapid atrial
tachyarrhythmias (ectopic atrial tachycardia, AV node reen-
trant tachycardia) may cause this physiologic mechanism to
overshoot or become irreversible. Direct evidence supporting
the role of calcium ion overload as part of the electrical
remodeling process was recently provided (25). Additional
mechanisms may involve imbalance between perfusion and
metabolic demand of the atrial myocardium, resulting in
ischemia-related action potential shortening (29), stretch of
atrial myocardium (30) and electrolyte or yet unknown intrin-
sic cardiomyopathic changes. The slow time course of the
development of and recovery from electrical remodeling might
also suggest modulation of ion channel expression. Yue et al.
(31) showed that after 1 to 7 days of rapid pacing in canine
hearts, the transient outward current (Ito) and L-type Ca
21
current were greatly reduced, and Van Wagoner et al. (32)
found that atrial myocytes excised from patients with chronic
AF had decreased density of outward potassium channels.
We cannot exclude that in our patients with atrial flutter
and AF, the underlying anatomic or pathophysiologic substrate
caused the electrical problem to some extent. In studies of
animals subjected to chronic atrial tachycardia, likewise, the
electrophysiologic abnormality may have developed subse-
quent to an abnormal mechanical or ischemic myocardial state.
Thus, it may not be entirely possible to resolve the chicken–egg
problem in this area. However, marked electrical remodeling
was found in previously healthy goats (11), and in our patients
the underlying heart disease or duration of AF/atrial flutter
(Fig. 4) was not a significant determinant of the extent of
electrical remodeling, suggesting that the abnormally rapid
rate of atrial depolarization itself was an important factor.
Atrial flutter versus AF. AF and atrial flutter are consid-
ered to be relatively disparate clinical entities in that particu-
lar, anatomically favored reentry mechanisms are thought
responsible for both typical and atypical flutter (33), whereas
AF may occur in enlarged atria that provide a greater oppor-
tunity for multiple wavelets to coexist or when the wavelength
of atrial excitation is shortened by disease or autonomic and
pharmacologic influences (34,35). The cycle length of atrial
flutter is usually significantly longer than that of AF. Typical
atrial flutter is characterized by cycle lengths of ;200 ms,
whereas atypical atrial flutter has cycle lengths averaging 150
to 220 ms (36). AF in the human heart is characterized by even
shorter (;136 to 174 ms) cycle lengths (37).
These differences in excitation cycle length between AF and
atrial flutter might be expected to produce quantitatively
different long-term effects on the APD of atrial myocardium.
However, this was not evident from our study, which showed
quantitatively similar abnormalities in APD after cardioversion
in patients with conversion from either AF or atrial flutter.
One possible explanation might be that the cycle length of
atrial flutter is sufficiently short to induce these persistent
changes in APD and that the shorter cycle length during AF
adds no further challenge to the mechanism or mechanisms
responsible for electrical remodeling of the atrial myocardium.
APD90 versus refractory period measurements. Most pre-
vious studies on the effect of AF or other atrial tachycardias
(spontaneous or electrically induced or maintained) used
measurements of the effective refractory period to assess the
effect of electrical remodeling. For the following reasons we
chose to measure instead the monophasic APD as a more
direct method of assessing electrical remodeling of AF/atrial
flutter: 1) Using the MAP pacing catheter, it was shown that
the APD90 correlates very closely with the effective refractory
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period over the entire physiologic cycle length range (45) and
thus serves as a valid surrogate of the effective refractory
period. 2) APD90 measurements with this method can be
made continuously during the pacing protocol and do not
require the introduction of a series of scanning extrastimuli, as
is needed for determinations of the refractory period. Such
repeated extrastimuli by themselves may perturb the measure-
ment objective (38) or even risk unwanted induction of AF or
atrial flutter that would require electrical cardioversion and
further disturb steady state conditions. 3) Disease conditions
(39,40) or antiarrhythmic drugs with sodium channel blocking
activity (41–46) may result in postrepolarization refractoriness,
which alters the normal relation between APD and refractori-
ness. Although the disparity between repolarization and re-
fractoriness is of importance in many situations, we judged that
measurements of APD90 would provide a “cleaner,” more
unperturbed measure of the effect of electrical remodeling.
Clinical implications. The present study demonstrates in
patients that chronic AF or atrial flutter leads to electrical
remodeling of the human atrial myocardium, as identified by
markedly abbreviated APDs as late as 15 to 30 min after
cardioversion. This finding may help to explain the high
recurrence rate of atrial tachyarrhythmias in these patients.
Persistent shortening of the atrial APD (and the associated
refractory period) after cardioversion from chronic atrial flut-
ter or AF has important clinical implications. A shorter
refractory period results in a shorter wavelength of the atrial
excitatory process and thereby allows an atrial premature
depolarization to occur earlier and find reentry conditions
more easily available than would otherwise be possible (34,35).
It therefore seems desirable to counteract the process of atrial
electrical remodeling caused by either AF or atrial flutter. This
could be done by either preempting the process of electrical
remodeling itself (potentially by calcium channel blockers or
future molecular biologic interventions) or by prolonging the
atrial action potential by class III drugs. Recent clinical trials
(47,48) showed that pure class III drugs can terminate AF and
atrial flutter and also help prevent their recurrence. Finally,
our finding that atrial flutter produced electrical remodeling of
the same magnitude as did AF suggests that it may be prudent
to abort atrial flutter early so as to not pave the way for the
development of chronic AF.
We thank Ross D. Fletcher, MD for continuing support in making this study
possible and Wijo Kopp, PhD for assistance with the statistical analysis.
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